Copertina

Ongoing Pharmacological Developments in SLC6A1 Research & Treatment

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Melissa B. DeLeeuw, Jacob Tiller, Jing‐Qiong Kang, Amber Freed
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Clinical Pharmacology & Therapeutics
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Progress in Clinical Pharmacology in China: An Ongoing Evolution
di: Liang Zhao, et al.
Pubblicazione: (2025)

Innovations in Clinical Pharmacology: Shaping the Future of Evidence Generation in Research, Development, and Utilization of Medicines
di: Karthik Venkatakrishnan, et al.
Pubblicazione: (2025)

Optimal Drug, Optimal Dose, or Both in the Pharmacological Treatment of Neonatal Opioid Withdrawal Syndrome?
di: Walter K. Kraft
Pubblicazione: (2025)

Correction to “Clinical Pharmacology and Translational Considerations in the Development of CRISPR‐Based Therapies”
Pubblicazione: (2025)

Bridging the Gap: Integrating Quantitative Systems Pharmacology and Pharmacometrics in Drug Development
di: Georgi I. Kapitanov, et al.
Pubblicazione: (2025)

Dosing Strategies and Quantitative Clinical Pharmacology for Bispecific T‐Cell Engagers Development in Oncology
di: Mohamed Elmeliegy, et al.
Pubblicazione: (2024)

Quantitative Systems Pharmacology Models: Potential Tools for Advancing Drug Development for Rare Diseases
di: Susana Neves‐Zaph, et al.
Pubblicazione: (2024)

Clinical Pharmacology Quality Assurance Program for Global HIV and Co‐Infection Drug Development
di: Robin DiFrancesco, et al.
Pubblicazione: (2026)

Subcutaneous Administration of Monoclonal Antibodies: Pharmacology, Delivery, Immunogenicity, and Learnings From Applications to Clinical Development
di: John D. Davis, et al.
Pubblicazione: (2024)

Pediatric Rare Diseases Development in the Pharmaceutical Industry: An International Consortium for Innovation and Quality in Pharmaceutical Development, Clinical Pharmacology Leadership Group‐Pediatrics Working Group, Rare Diseases Subteam Whitepaper Examining the Current Landscape and Recommendations for the Future
di: Rajesh Krishna, et al.
Pubblicazione: (2024)

Clinical and Quantitative Pharmacology Considerations of mRNA Therapeutics and Vaccine Development: Bridging Translational and Platform Gaps for Enhanced Decision Making
di: Linh M. Van, et al.
Pubblicazione: (2025)

The Future of Clinical Translational Pharmacology
di: Matthew L. Rizk, et al.
Pubblicazione: (2026)

Toward Developing Alternative Opioid Antagonists for Treating Community Overdose: A Model‐Based Evaluation of Important Pharmacological Attributes
di: Anik Chaturbedi, et al.
Pubblicazione: (2025)

Clinical Pharmacology Strategies for Bispecific Antibody Development: Learnings from FDA‐Approved Bispecific Antibodies in Oncology
di: KyoungSoo Lim, et al.
Pubblicazione: (2024)

History and Evolution of Innovations in Clinical Pharmacology
di: Lawrence J. Lesko, et al.
Pubblicazione: (2025)

American Society for Clinical Pharmacology and Therapeutics
Pubblicazione: (2026)

Modeling Supports Combinatorial Effects Between Pharmacological and Non‐Pharmacological Interventions to Prevent Opioid‐Induced Cardiac Arrest
di: Bradlee Thrasher, et al.
Pubblicazione: (2026)

Development and Validation of the Pharmacological Statin‐Associated Muscle Symptoms Risk Stratification Score Using Electronic Health Record Data
di: Boguang Sun, et al.
Pubblicazione: (2024)

The Role for Clinical Translational Pharmacology in Advancing Pharmacoequity
di: Sonya Tang Girdwood, et al.
Pubblicazione: (2025)

Industry Perspective on First‐in‐Human and Clinical Pharmacology Strategies to Support Clinical Development of T‐Cell Engaging Bispecific Antibodies for Cancer Therapy
di: Prathap Nagaraja Shastri, et al.
Pubblicazione: (2024)

From Global Impact to Pharmacoequity: A Call to Action for Clinical Pharmacology
di: Karen Rowland Yeo, et al.
Pubblicazione: (2026)

Clinical Pharmacology Considerations for the “Off‐the‐Shelf” Allogeneic Cell Therapies
di: Hardik Mody, et al.
Pubblicazione: (2024)

Getting the Dosage Right: A Vital Role for Clinical Pharmacology in the Era of Precision Medicine
di: Iris K. Minichmayr, et al.
Pubblicazione: (2024)

Clinical Pharmacology Characterization of Bispecific T‐Cell Engagers: A Summary Based on FDA Approvals
di: Ting Wang, et al.
Pubblicazione: (2025)

Leading the Way: Multi‐Drug Resistance Protein (MDR1) and Clinical Pharmacology—Commentary on Kim et al.
di: Kathleen M. Giacomini
Pubblicazione: (2025)

Cytochrome P450 2D6 Poor Metabolizers and Risperidone Treatment Failure: A 1‐Year Longitudinal Study
di: Marianna Piras, et al.
Pubblicazione: (2025)

Artificial Intelligence/Machine Learning: The New Frontier of Clinical Pharmacology and Precision Medicine
di: Qi Liu, et al.
Pubblicazione: (2024)

Clinical Pharmacology Approaches to Support Approval of New Routes of Administration for Therapeutic Proteins
di: Yow‐Ming C. Wang, et al.
Pubblicazione: (2024)

Cardiovascular‐Kidney‐Metabolic Syndrome in People With HIV : An Emerging Frontier for Clinical Pharmacology
di: Aaron S. Devanathan, et al.
Pubblicazione: (2025)

New Horizons for Clinical Pharmacology & Therapeutics : Global Outreach for Optimal Patient Outcomes
di: Karen Rowland Yeo
Pubblicazione: (2025)

Progress in Clinical Pharmacology in China: A Randomized Controlled Study to Advance Genotype‐Guided Precision Medicine
di: Liang Zhao, et al.
Pubblicazione: (2024)

MRI Provides New Insights Into the Pharmacologic Mechanism of Bisacodyl: A Blueprint for Understanding Intestinal Drug Mechanisms
di: Kathleen M. Giacomini
Pubblicazione: (2025)

A Comparative Clinical Pharmacology Analysis of FDA‐Approved Targeted Covalent Inhibitors vs. Reversible Inhibitors in Oncology
di: Huy X. Ngo, et al.
Pubblicazione: (2024)

Recommended Phase II Doses of Talquetamab in Patients With Relapsed/Refractory Multiple Myeloma From MonumenTAL‐1: Clinical Pharmacology Results
di: Jue Gong, et al.
Pubblicazione: (2025)

HIV Pharmacology Data Repository: Setting the New Information‐Sharing Standard for Clinical and Preclinical Pharmacokinetic Studies
di: Lauren A.R. Tompkins, et al.
Pubblicazione: (2025)

Optimizing Clinical Translation of Bispecific T‐cell Engagers through Context Unification with a Quantitative Systems Pharmacology Model
di: Xiaozhi Liao, et al.
Pubblicazione: (2024)

Quantitative Systems Pharmacology‐Based Digital Twins Approach Supplements Clinical Trial Data for Enzyme Replacement Therapies in Pompe Disease
di: Chanchala Kaddi, et al.
Pubblicazione: (2024)

Characterization of NAT, GST, and CYP2E1 Genetic Variation in Sub‐Saharan African Populations: Implications for Treatment of Tuberculosis and Other Diseases
di: Thandeka V.B. Malinga, et al.
Pubblicazione: (2025)

Optimal Treatment Based on Interferon No Longer Makes Clinical Cure of Chronic Hepatitis B Far Away: An Evidence‐Based Review on Emerging Clinical Data
di: Yujing Li, et al.
Pubblicazione: (2024)

Population Pharmacokinetic and Exposure‐Efficacy Analysis of Baloxavir Marboxil for Influenza Treatment and Post‐Exposure Prophylaxis in Children
di: Sylvie Retout, et al.
Pubblicazione: (2026)